258 related articles for article (PubMed ID: 11792747)
1. DNA repair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma.
Landi MT; Baccarelli A; Tarone RE; Pesatori A; Tucker MA; Hedayati M; Grossman L
J Natl Cancer Inst; 2002 Jan; 94(2):94-101. PubMed ID: 11792747
[TBL] [Abstract][Full Text] [Related]
2. Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma.
Wei Q; Lee JE; Gershenwald JE; Ross MI; Mansfield PF; Strom SS; Wang LE; Guo Z; Qiao Y; Amos CI; Spitz MR; Duvic M
J Natl Cancer Inst; 2003 Feb; 95(4):308-15. PubMed ID: 12591987
[TBL] [Abstract][Full Text] [Related]
3. [Risk factors of malignant skin melanoma in Italian population: review of results of a case-control study].
Baccarelli A; Landi MT
Epidemiol Prev; 2002; 26(6):293-9. PubMed ID: 12619494
[TBL] [Abstract][Full Text] [Related]
4. Radiation-induced chromatid breaks and DNA repair in blood lymphocytes of patients with dysplastic nevi and/or cutaneous melanoma.
Sanford KK; Parshad R; Price FM; Tarone RE; Thompson J; Guerry D
J Invest Dermatol; 1997 Oct; 109(4):546-9. PubMed ID: 9326388
[TBL] [Abstract][Full Text] [Related]
5. Melanocytic nevi and risk of cutaneous malignant melanoma in southern Spain.
Ródenas JM; Delgado-Rodríguez M; Farinas-Alvarez C; Herranz MT; Serrano S
Am J Epidemiol; 1997 Jun; 145(11):1020-9. PubMed ID: 9169911
[TBL] [Abstract][Full Text] [Related]
6. XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk.
Baccarelli A; Calista D; Minghetti P; Marinelli B; Albetti B; Tseng T; Hedayati M; Grossman L; Landi G; Struewing JP; Landi MT
Br J Cancer; 2004 Jan; 90(2):497-502. PubMed ID: 14735199
[TBL] [Abstract][Full Text] [Related]
7. Re: DNA repair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma.
Pedeux R; Boniol M; Autier P; Doré JF
J Natl Cancer Inst; 2002 May; 94(10):772-3; author reply 773-4. PubMed ID: 12011229
[No Abstract] [Full Text] [Related]
8. Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma.
Li C; Larson D; Zhang Z; Liu Z; Strom SS; Gershenwald JE; Prieto VG; Lee JE; Ross MI; Mansfield PF; Cormier JN; Duvic M; Grimm EA; Wei Q
Pharmacogenet Genomics; 2006 Apr; 16(4):253-63. PubMed ID: 16538172
[TBL] [Abstract][Full Text] [Related]
9. Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations.
Yang XR; Liang X; Pfeiffer RM; Wheeler W; Maeder D; Burdette L; Yeager M; Chanock S; Tucker MA; Goldstein AM
Fam Cancer; 2010 Dec; 9(4):625-33. PubMed ID: 20574843
[TBL] [Abstract][Full Text] [Related]
10. [Genetic counseling and DNA testing in patients with increased risks for malignant melanoma].
Itin PH; Fistarol SK
Ther Umsch; 2003 Aug; 60(8):469-72. PubMed ID: 14502854
[TBL] [Abstract][Full Text] [Related]
11. Age at diagnosis and transmission of invasive melanoma in 23 families with cutaneous malignant melanoma/dysplastic nevi.
Goldstein AM; Fraser MC; Clark WH; Tucker MA
J Natl Cancer Inst; 1994 Sep; 86(18):1385-90. PubMed ID: 8072031
[TBL] [Abstract][Full Text] [Related]
12. Melanocytes, moles and melanoma--a study on UV effects.
Stierner U
Acta Derm Venereol Suppl (Stockh); 1991; 168():1-31. PubMed ID: 1814138
[TBL] [Abstract][Full Text] [Related]
13. A relation between childhood sun exposure and dysplastic nevus syndrome among patients with nonfamilial melanoma.
Titus-Ernstoff L; Ernstoff MS; Duray PH; Barnhill RL; Holubkov R; Kirkwood JM
Epidemiology; 1991 May; 2(3):210-4. PubMed ID: 2054404
[TBL] [Abstract][Full Text] [Related]
14. Sunburn, sunscreens, and phenotypes: some risk factors for cutaneous melanoma in southern Brazil.
Bakos L; Wagner M; Bakos RM; Leite CS; Sperhacke CL; Dzekaniak KS; Gleisner AL
Int J Dermatol; 2002 Sep; 41(9):557-62. PubMed ID: 12358823
[TBL] [Abstract][Full Text] [Related]
15. Blood DNA methylation, nevi number, and the risk of melanoma.
Pergoli L; Favero C; Pfeiffer RM; Tarantini L; Calista D; Cavalleri T; Angelici L; Consonni D; Bertazzi PA; Pesatori AC; Landi MT; Bollati V
Melanoma Res; 2014 Oct; 24(5):480-7. PubMed ID: 25026000
[TBL] [Abstract][Full Text] [Related]
16. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis.
Wang LE; Xiong P; Strom SS; Goldberg LH; Lee JE; Ross MI; Mansfield PF; Gershenwald JE; Prieto VG; Cormier JN; Duvic M; Clayman GL; Weber RS; Lippman SM; Amos CI; Spitz MR; Wei Q
J Natl Cancer Inst; 2005 Dec; 97(24):1822-31. PubMed ID: 16368944
[TBL] [Abstract][Full Text] [Related]
17. Association of genetic variants in CDK6 and XRCC1 with the risk of dysplastic nevi in melanoma-prone families.
Liang X; Pfeiffer RM; Li WQ; Brossard M; Burke LS; Wheeler W; Calista D; Fargnoli MC; Ghiorzo P; Peris K; Bianchi-Scarra G; Chaudru V; Zelenika D; Maeder D; Burdette L; Yeager M; Chanock S; Landi MT; Demenais F; Tucker MA; Goldstein AM; Yang XR
J Invest Dermatol; 2014 Feb; 134(2):481-487. PubMed ID: 23892592
[TBL] [Abstract][Full Text] [Related]
18. Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families.
Chaudru V; Chompret A; Bressac-de Paillerets B; Spatz A; Avril MF; Demenais F
J Natl Cancer Inst; 2004 May; 96(10):785-95. PubMed ID: 15150307
[TBL] [Abstract][Full Text] [Related]
19. Indoor tanning exposure in association with multiple primary melanoma.
Karapetyan L; Yang X; Wang H; Sander CA; Moyer A; Wilson M; Karunamurthy A; Kirkwood JM
Cancer; 2021 Feb; 127(4):560-568. PubMed ID: 33170961
[TBL] [Abstract][Full Text] [Related]
20. Sunlight and dysplastic nevus risk. Results of a clinic-based case-control study.
Weinstock MA; Stryker WS; Stampfer MJ; Lew RA; Willett WC; Sober AJ
Cancer; 1991 Mar; 67(6):1701-6. PubMed ID: 2001561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
